Free Trial
OTCMKTS:FUJIY

Fujifilm Q1 2025 Earnings Report

Fujifilm logo
$10.63 -0.37 (-3.36%)
As of 04:00 PM Eastern

Fujifilm EPS Results

Actual EPS
$0.16
Consensus EPS
N/A
Beat/Miss
N/A
One Year Ago EPS
N/A

Fujifilm Revenue Results

Actual Revenue
$4.80 billion
Expected Revenue
N/A
Beat/Miss
N/A
YoY Revenue Growth
N/A

Fujifilm Announcement Details

Quarter
Q1 2025
Time
N/A
Conference Call Date
N/A
Conference Call Time
N/A

Upcoming Earnings

Fujifilm's next earnings date is estimated for Wednesday, August 5, 2026, based on past reporting schedules.

Conference Call Resources

Fujifilm Earnings Headlines

SpaceX is offering you shares. Don't take them.
SpaceX is reserving 30% of its IPO shares for retail investors through Robinhood, Fidelity, and Schwab. At a $1.75 trillion valuation and 266 times earnings, you're buying in at the most expensive IPO in history - right when institutions who got in at $800 billion need someone to sell to. Dylan Jovine has identified a small company in Musk's supply chain that builds the power infrastructure Colossus can't run without - and it's still trading at a fraction of its value.tc pixel
See More Fujifilm Headlines
Get Earnings Announcements in your inbox

Want to stay updated on the latest earnings announcements and upcoming reports for companies like Fujifilm? Sign up for Earnings360's daily newsletter to receive timely earnings updates on Fujifilm and other key companies, straight to your email.

About Fujifilm

Fujifilm (OTCMKTS:FUJIY) (OTCMKTS:FUJIY) is a Tokyo-based multinational conglomerate originally founded in 1934 as Fuji Photo Film Co., Ltd. Over the decades the company has evolved from a photographic film manufacturer into a diversified technology group operating across imaging, information, highly functional materials and healthcare. Fujifilm Holdings Corporation serves customers worldwide with a combination of hardware, consumables, software and services.

The company’s product and service portfolio spans consumer and professional imaging products, commercial and industrial printing systems, and office document solutions including printers and copiers. Fujifilm also develops and supplies highly functional materials and components used in electronics and manufacturing, such as specialty films, coatings and display materials. In healthcare and life sciences, the group offers diagnostic imaging systems, endoscopy equipment, in vitro diagnostics, and has a growing presence in pharmaceuticals and biopharmaceutical contract development and manufacturing.

Fujifilm conducts research and development through global R&D centers and operates manufacturing and sales networks across Asia, Europe, the Americas and other regions, supporting both local markets and international customers. The company’s strategy in recent years has emphasized diversification away from traditional photographic film into higher-growth areas such as medical technologies, bioprocessing services and advanced materials, leveraging its chemical and imaging expertise.

As a holdings group, Fujifilm is managed through an executive team based in Tokyo and a portfolio of operating subsidiaries that focus on specific markets and technologies. The company is known for technology-driven partnerships, investments in R&D and an ability to apply core competencies across consumer, industrial and healthcare sectors.

View Fujifilm Profile